Status:
COMPLETED
Family Studies of Inherited Heart Disease
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Hypertrophic Cardiomyopathy
Eligibility:
All Genders
Brief Summary
Hypertrophic cardiomyopathy (HCM) is a genetically inherited heart disease. It causes thickening of heart muscle, especially the chamber responsible for pumping blood out of the heart, the left ventri...
Detailed Description
Hypertrophic cardiomyopathy (HCM) is the most important cause of sudden death in apparently healthy young individuals but its clinical manifestations are highly variable. Linkage analysis is used to l...
Eligibility Criteria
INLUSION CRITERIA
Patients with a family history of hypertrophic cardiomyopathy are eligible.
Key Trial Info
Start Date :
April 1 1987
Trial Type :
OBSERVATIONAL
End Date :
August 1 2002
Estimated Enrollment :
5880 Patients enrolled
Trial Details
Trial ID
NCT00001225
Start Date
April 1 1987
End Date
August 1 2002
Last Update
March 4 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Heart, Lung and Blood Institute (NHLBI)
Bethesda, Maryland, United States, 20892